DSIJ Mindshare

Overnight Digest: Stocks to keep an eye on December 27
Armaan Madhani
/ Categories: Trending, Mindshare

Overnight Digest: Stocks to keep an eye on December 27

Nifty 50 ended the session at 18,014.6 with decent gains of 1.17 per cent

On Monday, Indian equity markets saw positive developments. Nifty 50 ended the session at 18,014.6 with decent gains of 1.17 per cent. All sectoral indices ended in green except pharmaceuticals and healthcare.  

Keep an eye on these stocks for Tuesday's trading session: 

Easy Trip Planners - The company announced the introduction of EMTFAMILY - an invite only, special programme for its elite shareholders. Under this programme, EaseMyTrip’s shareholders will be enrolled into a 'Refer Now & Earn Forever’ programme. Referrer will get exciting cash-backs on flights, hotels, holidays, buses and train bookings for a period of one year by referring a new user to book from EaseMyTrip website or mobile application. 

CAMS - The company has announced its collaboration with premier research institute, IIT Madras to launch CAMS IIT-M Fintech Innovation Lab (CIFIL), to accelerate financial technology related innovations. 

Alembic Pharmaceuticals - The company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Fulvestrant Injection. Fulvestrant injection is an estrogen receptor antagonist indicated for the treatment of breast cancer. Fulvestrant Injection has an estimated market size of USD 71 million for twelve months ending September 2022, according to IQVIA.  

Grindwell Norton - The company has commissioned its paper maker manufacturing plant in Bengaluru Under Atmanirbhar Bharat, the Paper Maker plant’s manufacturing capabilities presents a huge opportunity to introduce “Make in India” products that are innovative and have cutting edge technology. 

Previous Article Penny stock: Suzlon Energy surged 12 per cent today, ending a 4-day losing streak!
Next Article Stock below Rs 50: Shares of this company hit 10 per cent upper circuit today, find out why
Print
395 Rate this article:
3.9
Please login or register to post comments.
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR